Next month the FDA is hosting a public advisory committee meeting to discuss a change to the intended use of Dexcom's G5 Mobile Continuous Glucose Monitoring System (CGM) device that would allow the ...

The implementation of an inpatient continuous glucose monitoring policy was accurate and feasible among patients and nurses. Implementation of continuous glucose monitoring (CGM) in the hospital to ...

Continuous glucose monitoring is expanding beyond type 1 diabetes, offering detailed glycemic insights that may support earlier intervention in patients with type 2 diabetes.

Continuous glucose monitors are right now a good tool for a certain subset of people with diabetes, but there's still a majority of people, especially with Type 2 diabetes, for whom fingerstick ...

Emerging evidence points to potential benefits of continuous glucose monitoring (CGM) well beyond use as a management tool for people with diabetes who use insulin. Until recently, CGM use had been ...